Nada Suvajdžić
- Hematology top 1%
- Molecular Biology
- Genetics top 5%
- Pathology and Forensic Medicine top 10%
- Oncology
- Co-authors
- Dragica TominIvo ElezovićAna VidovićMirjana MitrovićMilica C̆olovićMarijana VirijevićAndrija BogdanovićIrena Đjunić
- Topics
- Acute Myeloid Leukemia Research (39 papers)Platelet Disorders and Treatments (27 papers)Blood groups and transfusion (16 papers)
- Cited by
- HematologyGeneticsInternal Medicine
In The Last Decade
Nada Suvajdžić
116 papers receiving 992 citations
Peers
Comparison fields: 5 of 83
- Hematology 649
- Molecular Biology 293
- Genetics 215
- Pathology and Forensic Medicine 140
- Oncology 135
Countries citing papers authored by Nada Suvajdžić
This map shows the geographic impact of Nada Suvajdžić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Suvajdžić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Suvajdžić more than expected).
Fields of papers citing papers by Nada Suvajdžić
This network shows the impact of papers produced by Nada Suvajdžić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Suvajdžić. The network helps show where Nada Suvajdžić may publish in the future.
Co-authorship network of co-authors of Nada Suvajdžić
This figure shows the co-authorship network connecting the top 25 collaborators of Nada Suvajdžić. A scholar is included among the top collaborators of Nada Suvajdžić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Suvajdžić. Nada Suvajdžić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 0 | |
| 9 | 7 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 21 | |
| 13 | 6 | |
| 14 | 9 | |
| 15 | 12 | |
| 16 | 8 | |
| 17 | 1 | |
| 18 | Dietary factors and multiple myeloma. Case-control study in Belgrade. | 1 |
| 19 | Clinical, Immunophenotypic and Cytogenetic Features of Megakaryocytic Blast Crisis of Chronic Myeloid Leukemia: A Single Institution Study. | 1 |
| 20 | Cytologically distinct acute leukemia in sibs exposed to the same leukemogen. | 1 |
About Nada Suvajdžić
Nada Suvajdžić is a scholar working on Hematology, Genetics and Internal Medicine, having authored 127 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), Platelet Disorders and Treatments (27 papers) and Blood groups and transfusion (16 papers). The work is most often cited by research in Hematology (649 citations), Genetics (215 citations) and Internal Medicine (37 citations). Nada Suvajdžić has collaborated with scholars based in Serbia, Czechia and Poland. Frequent co-authors include Dragica Tomin, Ivo Elezović, Ana Vidović, Mirjana Mitrović, Milica C̆olović, Marijana Virijević, Andrija Bogdanović, Irena Đjunić, Nataša Čolović and Gradimir Janković. Their work appears in journals such as JAMA, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.